Showing results (1-10 of 280) with videos related to
Sort By:
Pageof 28
PET Clinics|June 6, 2022
Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate CancerHossein Jadvar, Patrick M CollettiEuropean Journal of Radiology|June 25, 2013
Competitive advantage of PET/MRIHossein Jadvar, Patrick M CollettiThe British Journal of Radiology|April 10, 2018
<sup>18</sup>F-NaF/<sup>223</sup>RaCl<sub>2</sub> theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcomeHossein Jadvar, Patrick M CollettiJournal of Nuclear Medicine Technology|January 4, 2023
Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical TherapyHossein Jadvar, Patrick M CollettiEuropean Journal of Nuclear Medicine and Molecular Imaging|May 16, 2021
Targeted α-therapy in non-prostate malignanciesHossein Jadvar, Patrick M CollettiClinical Nuclear Medicine|September 17, 2005
FDG PET-CT demonstration of Sjogren's sialoadenitisHossein Jadvar, Shahram Bonyadlou, Andrei Iagaru, et al.Clinical Nuclear Medicine|May 16, 2018
Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone MetastasesAlbert Chau, Peter Gardiner, Patrick M Colletti, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Bone-Targeted Imaging and Radionuclide Therapy in Prostate CancerAndrei H Iagaru, Erik Mittra, Patrick M Colletti, et al.The British Journal of Radiology|January 28, 2025
Clinical Trials in Cancer Theranostics with Potential Near-Term Impact on Clinical PracticeHossein Jadvar, Abtin Doroudinia, Peter S Conti, et al.Theranostics|March 21, 2020
Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteriaErik M Velez, Bhushan Desai, Lingyun Ji, et al.Pageof 28